Skip to content

XOMA Corporation XOMA Total Liabilities

Total Liabilities at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$3.94M-96.4%
Royalty Pharma logo
Royalty PharmaRPRX
$9.88B+26.3%
Zymeworks logo
ZymeworksZYME
$314.63M+213%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$1.53B+31.4%
ALN
Alnylam PharmaceuticalsALNY
$4.05B-1.1%
Xencor logo
XencorXNCR
$221.21M-16.5%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's total liabilities?
XOMA Corporation (XOMA) reported total liabilities of $158.96M in Q1 2026.
How has XOMA Corporation's total liabilities changed year-over-year?
XOMA Corporation's total liabilities increased by 24.1% year-over-year, from $128.12M to $158.96M.
What is the long-term trend for XOMA Corporation's total liabilities?
Over 5 years (2020 to 2025), XOMA Corporation's total liabilities has grown at a 34.1% compound annual growth rate (CAGR), from $38.86M to $168.74M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.